Aprepitant Capsules and Dexbrompheniramine and phenylephrine
Determining the interaction of Aprepitant Capsules and Dexbrompheniramine and phenylephrine and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: aprepitant
Brand name: Cinvanti, Emend, Emend 3-Day, Emend 2-Day
Synonyms: Aprepitant
Generic Name: dexbrompheniramine / phenylephrine
Brand name: Ala Hist PE, Ala-Hist PE
Synonyms: Dexbrompheniramine and Phenylephrine
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Aprepitant Capsules-Dexbrompheniramine and Phenylephrine Syrup
- Aprepitant Capsules-Dexbrompheniramine and Phenylephrine Tablets
- Aprepitant Capsules-Dexbrompheniramine and pseudoephedrine
- Aprepitant Capsules-Dexbrompheniramine and Pseudoephedrine Solution
- Aprepitant Capsules-Dexbrompheniramine and Pseudoephedrine Sustained-Release Tablets
- Aprepitant Capsules-Dexbrompheniramine and Pseudoephedrine Tablets
- Dexbrompheniramine and phenylephrine-Aprepitant Injection
- Dexbrompheniramine and phenylephrine-Aprepitant Intravenous
- Dexbrompheniramine and phenylephrine-Aprepitant Oral Suspension
- Dexbrompheniramine and phenylephrine-Aprepitant/Fosaprepitant Dimeglumine
- Dexbrompheniramine and phenylephrine-Apresazide
- Dexbrompheniramine and phenylephrine-Apresoline